Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piccart

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2020
Immunotherapy for early breast cancer: too soon, too superficial, or just right?M A Franzoi, E Romano, M Piccart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?J A Roy, D de Valeriola, M Piccart
Seminars in Oncology|March 1, 1982
The cardiotoxicity of anticancer agentsD D Von Hoff, M Rozencweig, M Piccart
Cancer Treatment Reviews|July 1, 1996
Use of bisphosphonates in cancer patientsJ J Body, R E Coleman, M Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancerM Piccart, L M Parker, K I Pritchard
Cancer|May 1, 1988
Ureteral obstruction in patients with breast cancerP Recloux, M Weiser, M Piccart, et al.
Revue Medicale De Bruxelles|March 1, 1990
Lethal anuria complicating high dose ifosfamide chemotherapy in a breast cancer patient with an impaired renal functionV Richard, M Piccart, R Paridaens, et al.
Oncology|November 6, 2001
The predictive value of HER2 in breast cancerM Piccart, C Lohrisch, A Di Leo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer CenterS B Kaye, M Piccart, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Phase I and pharmacokinetic study of weekly oral therapy with vinorelbine in patients with advanced breast cancer (ABC)J Bonneterre, B Chevalier, C Focan, et al.
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2020
Immunotherapy for early breast cancer: too soon, too superficial, or just right?M A Franzoi, E Romano, M Piccart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed?J A Roy, D de Valeriola, M Piccart
Seminars in Oncology|March 1, 1982
The cardiotoxicity of anticancer agentsD D Von Hoff, M Rozencweig, M Piccart
Cancer Treatment Reviews|July 1, 1996
Use of bisphosphonates in cancer patientsJ J Body, R E Coleman, M Piccart
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancerM Piccart, L M Parker, K I Pritchard
Cancer|May 1, 1988
Ureteral obstruction in patients with breast cancerP Recloux, M Weiser, M Piccart, et al.
Revue Medicale De Bruxelles|March 1, 1990
Lethal anuria complicating high dose ifosfamide chemotherapy in a breast cancer patient with an impaired renal functionV Richard, M Piccart, R Paridaens, et al.
Oncology|November 6, 2001
The predictive value of HER2 in breast cancerM Piccart, C Lohrisch, A Di Leo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer CenterS B Kaye, M Piccart, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Phase I and pharmacokinetic study of weekly oral therapy with vinorelbine in patients with advanced breast cancer (ABC)J Bonneterre, B Chevalier, C Focan, et al.
Pageof 19